Stephen V Liu, MD (@stephenvliu) 's Twitter Profile
Stephen V Liu, MD

@stephenvliu

Director of Thoracic Oncology & Developmental Therapeutics @Georgetown @LombardiCancer; Co-Host @IASLC Podcast; Chair #TexasLung25 #DCLung25; #HereWeGo

ID: 377425889

linkhttps://www.medstarhealth.org/doctors/stephen-liu-md calendar_today21-09-2011 15:17:53

19,19K Tweet

26,26K Takipçi

3,3K Takip Edilen

Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

Dr. Herbert Loong, MBBS, FASCO at #ASCO25 with update on SOHO-01 with sevanertinib (BAY 2927088) in #HER2 NSCLC. RR 60.5% in pts with prior treatment (no HER2 therapy), DOR 9.2m. In 1L setting, RR 59% and most ongoing. Safety notable for >80% of pts with diarrhea though.

Dr. <a href="/herbloong/">Herbert Loong, MBBS, FASCO</a> at #ASCO25 with update on SOHO-01 with sevanertinib (BAY 2927088) in #HER2 NSCLC. RR 60.5% in pts with prior treatment (no HER2 therapy), DOR 9.2m. In 1L setting, RR 59% and most ongoing. Safety notable for &gt;80% of pts with diarrhea though.